Literature DB >> 19200811

Novel SIVmac DNA vaccines encoding Env, Pol and Gag consensus proteins elicit strong cellular immune responses in cynomolgus macaques.

Jian Yan1, David A Hokey, Matthew P Morrow, Natasha Corbitt, Kristina Harris, Drea Harris, David B Weiner.   

Abstract

Cellular immunity plays an important role in controlling HIV-1 replication. One of the major challenges in developing an HIV-1 DNA vaccine is to generate broader and more potent cellular responses. In this study, we constructed three novel constructs expressing SIVmac antigens Env, Pol and Gag, respectively, with the goal of increasing anti-SIV cellular immunity. The results demonstrate that these constructs can induce strong cellular immune responses in a murine model. Moreover, when applied to cynomolgus macaques, these constructs are not only able to elicit robust IFN-gamma effector responses, but also induce SIV antigen-specific CD8(+) T cells that have high proliferative capacity. These data suggest that such DNA immunogens deserve further examination for their potential to control viral replication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200811     DOI: 10.1016/j.vaccine.2009.01.065

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques.

Authors:  Lauren A Hirao; Ling Wu; Abhishek Satishchandran; Amir S Khan; Ruxandra Draghia-Akli; Adam C Finnefrock; Andrew J Bett; Michael R Betts; Danilo R Casimiro; Niranjan Y Sardesai; J Joseph Kim; John W Shiver; David B Weiner
Journal:  Mol Ther       Date:  2010-06-15       Impact factor: 11.454

2.  Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccine.

Authors:  Géraldine Arrode-Brusés; Darlene Sheffer; Ramakrishna Hegde; Sukbir Dhillon; Zhengian Liu; François Villinger; Opendra Narayan; Yahia Chebloune
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

3.  IL-4 and IFN-γ induced by human immunodeficiency virus vaccine in a schistosome infection model.

Authors:  Jiangmei Yin; Anlan Dai; Tatiana Arango; Ravi S Kasinathan; Robert M Greenberg; Jean D Boyer
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

4.  IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques.

Authors:  Matthew P Morrow; Jian Yan; Panyupa Pankhong; Devon J Shedlock; Mark G Lewis; Kendra Talbott; Roberta Toporovski; Amir S Khan; Niranjan Y Sardesai; David B Weiner
Journal:  Mol Ther       Date:  2010-06-22       Impact factor: 11.454

5.  Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques.

Authors:  Kimberly A Kraynyak; Michele A Kutzler; Neil J Cisper; Amir S Khan; Ruxandra Draghia-Akli; Niranjan Y Sardesal; Mark G Lewis; Jian Yan; David B Weiner
Journal:  Vaccine       Date:  2010-02-23       Impact factor: 3.641

6.  Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques.

Authors:  Diane G Carnathan; Katherine S Wetzel; Joana Yu; S Thera Lee; Brent A Johnson; Mirko Paiardini; Jian Yan; Matthew P Morrow; Niranjan Y Sardesai; David B Weiner; Hildegund C J Ertl; Guido Silvestri
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-30       Impact factor: 11.205

7.  Plasmodium inui infection reduces the efficacy of a simian immunodeficiency virus DNA vaccine in a rhesus macaque model through alteration of the vaccine-induced immune response.

Authors:  Jiangmei Yin; Maryanne T Vahey; Anlan Dai; Mark G Lewis; Tatiana Arango; Jake Yalley-Ogunro; Jack Greenhouse; Karla Mendoza; Amir Khan; Niranjan Y Sardesai; Walter Weiss; Jack Komisar; Jean D Boyer
Journal:  J Infect Dis       Date:  2012-06-12       Impact factor: 5.226

8.  Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA.

Authors:  B Ferraro; K T Talbott; A Balakrishnan; N Cisper; M P Morrow; N A Hutnick; D J Myles; D J Shedlock; N Obeng-Adjei; J Yan; A K K Kayatani; N Richie; W Cabrera; R Shiver; A S Khan; A S Brown; M Yang; U Wille-Reece; A J Birkett; N Y Sardesai; D B Weiner
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

9.  The porcine circovirus type 1 capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccine.

Authors:  Fiona L Tanzer; Enid G Shephard; Kenneth E Palmer; Marieta Burger; Anna-Lise Williamson; Edward P Rybicki
Journal:  Virol J       Date:  2011-02-07       Impact factor: 4.099

10.  Immune modulation through 4-1BB enhances SIV vaccine protection in non-human primates against SIVmac251 challenge.

Authors:  Lauren A Hirao; David A Hokey; Matthew P Morrow; Maria N Jure-Kunkel; David B Weiner
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.